| |
|---|---|
| Accession Number: | P05067 |
| Protein Name: | Amyloid beta A4 protein |
| Length: | 770 |
| Molecular Weight: | 86943.00 |
| Species: | Homo sapiens (Human) [9606] |
| Number of TMSs: | 1 |
| Location1 / Topology2 / Orientation3: | Membrane1 / Single-pass type I membrane protein2 |
| Substrate | ion |
Cross database links:
| DIP: | DIP-574N |
|---|---|
| RefSeq: | NP_000475.1 NP_001129601.1 NP_001129602.1 NP_958816.1 NP_958817.1 |
| Entrez Gene ID: | 351 |
| Pfam: | PF02177 PF10515 PF03494 PF00014 |
| OMIM: |
104300 phenotype 104760 gene+phenotype 605714 phenotype |
| KEGG: | hsa:351 |
Gene Ontology
GO:0030424
C:axon
GO:0009986
C:cell surface
GO:0005905
C:coated pit
GO:0043198
C:dendritic shaft
GO:0043197
C:dendritic spine
GO:0005576
C:extracellular region
GO:0005794
C:Golgi apparatus
GO:0005887
C:integral to plasma membrane
GO:0031093
C:platelet alpha granule lumen
GO:0033130
F:acetylcholine receptor binding
GO:0003677
F:DNA binding
GO:0008201
F:heparin binding
GO:0042802
F:identical protein binding
GO:0046872
F:metal ion binding
GO:0004867
F:serine-type endopeptidase inhibitor activity
GO:0008344
P:adult locomotory behavior
GO:0008088
P:axon cargo transport
GO:0016199
P:axon midline choice point recognition
GO:0007155
P:cell adhesion
GO:0006878
P:cellular copper ion homeostasis
GO:0048669
P:collateral sprouting in the absence of injury
GO:0016358
P:dendrite development
GO:0006897
P:endocytosis
GO:0030198
P:extracellular matrix organization
GO:0000085
P:G2 phase of mitotic cell cycle
GO:0035235
P:ionotropic glutamate receptor signaling pat...
GO:0007617
P:mating behavior
GO:0006378
P:mRNA polyadenylation
GO:0051402
P:neuron apoptosis
GO:0016322
P:neuron remodeling
GO:0007219
P:Notch signaling pathway
GO:0045931
P:positive regulation of mitotic cell cycle
GO:0006468
P:protein amino acid phosphorylation
GO:0007176
P:regulation of epidermal growth factor recep...
GO:0040014
P:regulation of multicellular organism growth
GO:0050803
P:regulation of synapse structure and activity
GO:0006417
P:regulation of translation
GO:0008542
P:visual learning
| |
References (129)[1] “The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.” Kang J.et.al. 2881207 [2] “A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors.” Ponte P.et.al. 2893289 [3] “The PreA4(695) precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons.” Lemaire H.-G.et.al. 2783775 [4] “Genomic organization of the human amyloid beta-protein precursor gene.” Yoshikai S.et.al. 2110105 [5] “” Yoshikai S.et.al. 1908403 [6] “Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells.” Koenig G.et.al. 1587857 [7] “A novel method for making nested deletions and its application for sequencing of a 300 kb region of human APP locus.” Hattori M.et.al. 9108164 [8] “Identification of a novel alternative splicing isoform of human amyloid precursor protein gene, APP639.” Tang K.et.al. 12859342 [9] “Complete sequencing and characterization of 21,243 full-length human cDNAs.” Ota T.et.al. 14702039 [10] “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).” The MGC Project Teamet.al. 15489334 [11] “A cDNA specifying the human amyloid beta precursor protein (ABPP) encodes a 95-kDa polypeptide.” Schon E.A.et.al. 3140222 [12] “Characterization of the 5'-end region and the first two exons of the beta-protein precursor gene.” La Fauci G.et.al. 2538123 [13] “Purification of protease nexin II from human fibroblasts.” van Nostrand W.E.et.al. 3597385 [14] “Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.” Gevaert K.et.al. 12665801 [15] “Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.” Tanzi R.E.et.al. 2893290 [16] “Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.” Kitaguchi N.et.al. 2893291 [17] “Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer disease brain: coding and noncoding regions of the fetal precursor mRNA are expressed in the cortex.” Zain S.B.et.al. 2893379 [18] “Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I.” Beher D.et.al. 8576160 [19] “A system for studying the effect(s) of familial Alzheimer disease mutations on the processing of the beta-amyloid peptide precursor.” Denman R.B.et.al. 8476439 [20] “Alzheimer's disease amyloid peptide is encoded by two exons and shows similarity to soybean trypsin inhibitor.” Johnstone E.M.et.al. 2675837 [21] “Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease.” Wakutani Y.et.al. 15201367 [22] “Beta-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.” Roher A.E.et.al. 8248178 [23] “Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.” Seubert P.et.al. 1406936 [24] “The amino acid sequence of neuritic plaque amyloid from a familial Alzheimer's disease patient.” Wisniewski T.et.al. 8109908 [25] “Characterization of beta-amyloid peptide from human cerebrospinal fluid.” Vigo-Pelfrey C.et.al. 8229004 [26] “Amyloid angiopathy of Alzheimer's disease: amino acid composition and partial sequence of a 4,200-dalton peptide isolated from cortical microvessels.” Pardridge W.M.et.al. 3312495 [27] “Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease.” Goldgaber D.et.al. 3810169 [28] “Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.” Tanzi R.E.et.al. 2949367 [29] “BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome.” Sun X.et.al. 16816112 [30] “A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein.” de Sauvage F.et.al. 2569763 [31] “Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides.” Robakis N.K.et.al. 3035574 [32] “The chondroitin sulfate attachment site of appican is formed by splicing out exon 15 of the amyloid precursor gene.” Pangalos M.N.et.al. 7737970 [33] “Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.” Walter M.F.et.al. 9168929 [34] “Alzheimer's amyloid-beta as a preventive antioxidant for brain lipoproteins.” Kontush A.et.al. 11775062 [35] “The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II.” Oltersdorf T.et.al. 2506449 [36] “Protease-specificity of Kunitz inhibitor domain of Alzheimer's disease amyloid protein precursor.” Kido H.et.al. 1969731 [37] “A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease.” Bush A.I.et.al. 8344894 [38] “Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o).” Nishimoto I.et.al. 8446172 [39] “The beta A4 amyloid precursor protein binding to copper.” Hesse L.et.al. 7913895 [40] “A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth.” Small D.H.et.al. 8158260 [41] “Familial Alzheimer's disease-linked mutations at Val717 of amyloid precursor protein are specific for the increased secretion of A beta 42(43).” Maruyama K.et.al. 8886002 [42] “APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein.” Chow N.et.al. 8626687 [43] “The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein.” Borg J.-P.et.al. 8887653 [44] “Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein.” Guenette S.Y.et.al. 8855266 [45] “Expression and analysis of heparin-binding regions of the amyloid precursor protein of Alzheimer's disease.” Mok S.S.et.al. 9357988 [46] “An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease.” Yan S.D.et.al. 9338779 [47] “PAT1, a microtubule-interacting protein, recognizes the basolateral sorting signal of amyloid precursor protein.” Zheng P.et.al. 9843960 [48] “Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease.” Liu S.T.et.al. 10413512 [49] “Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress.” Varadarajan S.et.al. 10535332 [50] “Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein.” Tomita S.et.al. 9890987 [51] “Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42.” Perez R.G.et.al. 10383380 [52] “Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein.” Ruiz F.H.et.al. 10461923 [53] “Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides.” Tokuda T.et.al. 10816430 [54] “Beta-amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.” Wang H.-Y.et.al. 10681545 [55] “Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor.” Passer B.et.al. 12214090 [56] “Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages.” Yazawa H.et.al. 11689470 [57] “Beta-amyloid peptide-induced apoptosis regulated by a novel protein containing a G protein activation module.” Kajkowski E.M.et.al. 11278849 [58] “Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered structure containing superoxide dismutase-like subunits.” Curtain C.C.et.al. 11274207 [59] “Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease.” Scheuermann S.et.al. 11438549 [60] “The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner.” Kimberly W.T.et.al. 11544248 [61] “Fibulin-1 binds the amino-terminal head of beta-amyloid precursor protein and modulates its physiological function.” Ohsawa I.et.al. 11238726 [62] “Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II.” Rank K.B.et.al. 11943163 [63] “Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein (APP).” Scheinfeld M.H.et.al. 11724784 [64] “Contrasting species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.” White A.R.et.al. 11784781 [65] “The galvanization of beta-amyloid in Alzheimer's disease.” Bush A.I.et.al. 12032279 [66] “Amyloid-beta protein precursor (AbetaPP) intracellular domain-associated protein-1 proteins bind to AbetaPP and modulate its processing in an isoform-specific manner.” Ghersi E.et.al. 15347684 [67] “Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein.” Suzuki T.et.al. 8131745 [68] “Ectodomain phosphorylation of beta-amyloid precursor protein at two distinct cellular locations.” Walter J.et.al. 8999878 [69] “Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide.” Multhaup G.et.al. 9585534 [70] “Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation.” Gervais F.G.et.al. 10319819 [71] “Role of phosphorylation of Alzheimer's amyloid precursor protein during neuronal differentiation.” Ando K.et.al. 10341243 [72] “Phosphorylation of the beta-amyloid precursor protein at the cell surface by ectocasein kinases 1 and 2.” Walter J.et.al. 10806211 [73] “A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor.” Lu D.C.et.al. 10742146 [74] “Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid.” Ando K.et.al. 11517218 [75] “Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3).” Standen C.L.et.al. 11146006 [76] “A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing.” Weidemann A.et.al. 11851430 [77] “Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc.” Tarr P.E.et.al. 11877420 [78] “Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.” Liu T.et.al. 16335952 [79] “Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease.” Dyrks T.et.al. 2900137 [80] “A cell biological perspective on Alzheimer's disease.” Annaert W.et.al. 12142279 [81] “Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.” Rikova K.et.al. 18083107 [82] “Regulation of FE65 nuclear translocation and function by amyloid beta-protein precursor in osmotically stressed cells.” Nakaya T.et.al. 18468999 [83] “BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2.” Matsuda S.et.al. 19366692 [84] “An extensive survey of tyrosine phosphorylation revealing new sites in human mammary epithelial cells.” Heibeck T.H.et.al. 19534553 [85] “APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.” Nikolaev A.et.al. 19225519 [86] “RAGE-mediated signaling contributes to intraneuronal transport of amyloid-{beta} and neuronal dysfunction.” Takuma K.et.al. 19901339 [87] “X-ray crystal structure of the protease inhibitor domain of Alzheimer's amyloid beta-protein precursor.” Hynes T.R.et.al. 2125487 [88] “Sequential NMR resonance assignment and structure determination of the Kunitz-type inhibitor domain of the Alzheimer's beta-amyloid precursor protein.” Heald S.L.et.al. 1718421 [89] “Solution structure of residues 1-28 of the amyloid beta-peptide.” Talafous J.et.al. 7516706 [90] “Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease.” Sticht H.et.al. 7588758 [91] “Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment.” Kohno T.et.al. 8973180 [92] “Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.” Scheidig A.J.et.al. 9300481 [93] “Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?” Coles M.et.al. 9693002 [94] “Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein.” Rossjohn J.et.al. 10201399 [95] “Substitutions at codon 22 of Alzheimer's Abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells.” Miravalle L.et.al. 10821838 [96] “The Alzheimer's peptide a beta adopts a collapsed coil structure in water.” Zhang S.et.al. 10940221 [97] “Solution structures in aqueous SDS micelles of two amyloid beta peptides of Abeta(1-28) mutated at the alpha-secretase cleavage site.” Poulsen S.-A.et.al. 10940222 [98] “The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain.” Wang Y.et.al. 15304215 [99] “Framing beta-amyloid.” Hardy J.et.al. 1363811 [100] “Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.” Levy E.et.al. 2111584 [101] “Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.” Goate A.et.al. 1671712 [102] “The 717Val-->Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups.” Yoshioka K.et.al. 1908231 [103] “Mis-sense mutation Val->Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease.” Naruse S.et.al. 1678058 [104] “Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.” Chartier-Harlin M.-C.et.al. 1944558 [105] “A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.” Murrell J.R.et.al. 1925564 [106] “Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.” Kamino K.et.al. 1415269 [107] “Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.” Hendriks L.et.al. 1303239 [108] “A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid.” Mullan M.et.al. 1302033 [109] “Mutation in codon 713 of the beta amyloid precursor protein gene presenting with schizophrenia.” Jones C.T.et.al. 1307241 [110] “More missense in amyloid gene.” Carter D.A.et.al. 1303275 [111] “Characterization of amyloid fibril beta-peptide in familial Alzheimer's disease with APP717 mutations.” Liepnieks J.J.et.al. 8267572 [112] “Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease.” Peacock M.L.et.al. 8154870 [113] “Clinical characteristics in a kindred with early-onset Alzheimer's disease and their linkage to a G-->T change at position 2149 of the amyloid precursor protein gene.” Farlow M.et.al. 8290042 [114] “A mutation in codon 717 of the amyloid precursor protein gene in an Australian family with Alzheimer's disease.” Brooks W.S.et.al. 8577393 [115] “A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43).” Eckman C.B.et.al. 9328472 [116] “Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala-->Gly mutation.” Cras P.et.al. 9754958 [117] “Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease.” Ancolio K.et.al. 10097173 [118] “High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.” Finckh U.et.al. 10631141 [119] “Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis.” Kwok J.B.J.et.al. 10665499 [120] “Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene.” Murrell J.R.et.al. 10867787 [121] “Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease.” Kumar-Singh S.et.al. 11063718 [122] “Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy.” Grabowski T.J.et.al. 11409420 [123] “In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.” Walsh D.M.et.al. 11311152 | |